Fabrice André

68PUBLICATIONS
579CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|Aug 12, 2026
Rb-driven transcription limits its tumour-suppressive effects in breast cancer.

|Mar 09, 2026
VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer.

Sara A Hurvitz, Rachel M Layman, Giuseppe Curigliano

|Feb 03, 2026
Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors.

Francesco Facchinetti, Antoine Hollebecque, Rémy Barbé

|Jan 08, 2026
DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer.

Komal Jhaveri, Sherene Loi, Erika Hamilton

|Dec 10, 2025
Novae: a graph-based foundation model for spatial transcriptomics data.

Quentin Blampey, Hakim Benkirane, Nadège Bercovici

|Oct 21, 2025
Working conditions associated with return to work 2 years after breast cancer: insights from a cohort study.

Garazi Ruiz de Azua, Idlir Licaj, Sandrine Pinto

Pageof 12

Frequent Collaborators

13 joint publications

Barbara Pistilli

11 joint publications

Stefan Michiels

8 joint publications

Benjamin Besse

8 joint publications

Anne-Laure Martin